Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 41 Show results per page	View Search Criteria \| Help With Results


1.		Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRD

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				18 to 59				Other				N06IAA NCT00448266

Last Modified: 6/9/2008 First Published: 9/26/2007


2.		Phase II/III Study of Disease-Specific High-Dose Conditioning Regimens Followed by Autologous Stem Cell Transplantation (Single or Tandem) in Patients With Hematologic Malignancies or Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				4 and over				NCI				RPCI-I-72806 I 72806, NCT00536601


3.		Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				0 to 30				Other				EUDRACT 2005-002618-40 BfArM-4030755, EC-105/05, DKS 2006.01, NCT00749723

Last Modified: 9/19/2008 First Published: 6/2/2006


4.		Phase III Randomized Study of Induction Chemotherapy Comprising Vincristine, Etoposide, Cyclophosphamide, and Cisplatin With or Without High-Dose Methotrexate and Leucovorin Calcium Followed by Consolidation Chemotherapy Comprising Carboplatin and Thiotepa and Peripheral Blood Stem Cell Rescue in Pediatric Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Biomarker/Laboratory analysis, Treatment				Active				Under 3				NCI				COG-ACNS0334 ACNS0334, NCT00336024

Last Modified: 9/9/2008 First Published: 9/23/2006


5.		Phase III Randomized Study of Graft-Versus-Host Disease Prophylaxis Comprising Tacrolimus and Methotrexate With or Without Sirolimus in Pediatric Patients With Intermediate-Risk or High-Risk Acute Lymphoblastic Leukemia in Second Complete Remission Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				1 to 21 at first relapse				NCI				COG-ASCT0431 ASCT0431, COG-PBMTC-ONCO51, NCT00382109

Last Modified: 6/11/2008 First Published: 10/21/2006


6.		Phase III Pilot Study of Induction Chemotherapy Followed by Consolidation Myeloablative Chemotherapy Comprising Thiotepa and Carboplatin With or Without Etoposide and Autologous Hematopoietic Stem Cell Rescue in Pediatric Patients With Previously Untreated Malignant Brain Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Under 10 at diagnosis				Other				CHLA-HEAD-START-III CHLA-HSIII, CHLA-2004-020, CHLA-04.020, NCT00392886, UMN-MT2004-06

Last Modified: 9/18/2008 First Published: 3/16/2007


7.		Phase III Randomized Study of Filgrastim (G-CSF)-Stimulated Allogeneic Bone Marrow Transplantation Versus Conventional Bone Marrow Transplantation in Pediatric Patients With Hematologic Cancer or Other Diseases

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Under 22				NCI				COG-ASCT0631 ASCT0631, COG-PBMTC-STC051, NCT00450450

Last Modified: 9/5/2008 First Published: 11/2/2007


8.		Phase III Study of Multimodality Therapy Comprising Induction Chemotherapy, High-Dose Consolidation Chemotherapy, Autologous Stem Cell Transplantation, and/or Radiotherapy in Children With Extraocular Retinoblastoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				10 and under				NCI				COG-ARET0321 ARET0321, NCT00554788

Last Modified: 9/19/2008 First Published: 12/3/2007


9.		Phase III Randomized Study of Single Versus Tandem Myeloablative Consolidation Therapy Followed by Peripheral Blood Stem Cell Transplantation in Young Patients With High-Risk Neuroblastoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Biomarker/Laboratory analysis, Treatment				Active				30 and under				NCI				COG-ANBL0532 ANBL0532, NCT00567567

Last Modified: 8/25/2008 First Published: 4/2/2008


10.		Phase III Study of Induction Therapy Comprising Vincristine, High-Dose Methotrexate, Leucovorin Calcium, Etoposide, Cisplatin, and Cyclophosphamide Followed by 3-Dimensional Conformal Radiotherapy and High-Dose Consolidation Therapy Comprising Carboplatin, Thiotepa, and Autologous Peripheral Blood Stem Cell Rescue in Pediatric Patients With Atypical Teratoid/Rhabdoid Tumors of the Central Nervous System

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Biomarker/Laboratory analysis, Treatment				Approved-not yet active				21 and under at the time of definitive surgery				NCI				COG-ACNS0333 ACNS0333, NCT00653068

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute